Michael Safdi - Concepedia

Author

Michael Safdi

Atlanta Gastroenterology Associates

Also Known As

D Wolf, M A Safdi, M Safdi, M. Safdi, Michael A Safdi, Michael A. Safdi, Michael Safdi, Nicholas J. Shaheen

Publications

Citations

H-Index

Concepts

All Affiliations

Atlanta Gastroenterology Associates University of Chicago Clinical Research Associates Clinical Research Consultants (United States)University of Chicago Medical Center

About

Michael Safdi is an author at Atlanta Gastroenterology Associates specializing in gastroenterology, medicine, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	3K
2	Allergy	2	2	24
3	Health Sciences	1	1	31
4	Anesthesia	1	1	18
5	Emergency Medicine	1	1	212

Michael Safdi

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial William J. Sandborn, S. B. Hanauer, Seymour Katz, Gastroenterology Functional Gastrointestinal DisorderGastroenterologyClinical TrialsClinical GastroenterologyUlcerative Colitis	2001	905
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease Paul Rutgeerts, Robert H. Diamond, Mohan Bala, Gastrointestinal Endoscopy InflammationAnti-inflammatoryMaintenance TreatmentGastroenterologySurgery	2006	546
A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis Michael Safdi, Michael DeMicco, Charles A. Sninsky, Gastroenterology Distal Ulcerative ColitisGastroenterologyClinical GastroenterologySurgeryUlcerative Colitis	1995	324
Delayed-Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the Treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial Stephen B. Hanauer, William J. Sandborn, Asher Kornbluth, The American Journal of Gastroenterology	2005	323
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection Miguel Regueiro, Brian G. Feagan, Bin Zou, Gastroenterology	2016	320
Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. S. Hanauer, JACOB SCHWARTZ, Malcolm Robinson, PubMed Anti-inflammatoryFunctional Gastrointestinal DisorderMesalamine CapsulesGastrointestinal PharmacologyGastroenterology	1993	269
Quality Indicators for Endoscopic Retrograde Cholangiopancreatography Todd H. Baron, Bret T. Petersen, Klaus Mergener, The American Journal of Gastroenterology Gastroenterology Task ForceGastroenterologyDiagnosisSurgeryEndoscopic Imaging	2006	212
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease Bruce E. Sands, Simmy Bank, Charles A. Sninsky, Gastroenterology InflammationAutoimmune DiseaseMucosal ImmunologyPreliminary EvaluationImmunology	1999	205
Superiority of Lansoprazole vs Ranitidine in Healing Nonsteroidal Anti-inflammatory Drug–Associated Gastric Ulcers Naurang M. Agrawal, Donald R. Campbell, Michael Safdi, Archives of Internal Medicine	2000	149
Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease Bruce E. Sands, Barry Winston, Bruce Salzberg, Alimentary Pharmacology & Therapeutics	2002	139

Page 1